Happi Staff09.11.19
Aivita Biomedical Inc., a biotech company specializing in innovative stem cell applications, has launched its professional Root of Skin MD brand of rejuvenating skincare products in Japan. A launch event attended by beauty industry press, the CEOs of both Air Group and Aivita, and various influencers in the sector was held at the office of Air Group in Ginza, Tokyo on August 27, 2019.
Headquartered in Tokyo, Air Group is the Japanese agent of several global beauty brands and has a network of 300 high end beauty salons across Japan. Aivita’s Root of Skin MD products will be carried in Air Group affiliated salons with medical professionals.
Root of Skin MD is Aivita’s professional skincare line for skin rejuvenation, made possible through the same proprietary knowledge and expertise used to develop its cell therapies. The all-new actives complex SourceCode Technology contains the complete set of factors and supporting biological components present in young, healthy skin. Aivita uses 100% of proceeds from the sale of its professional Root of Skin MD skincare line and its consumer Root of Skin skincare line to support the treatment of women with ovarian cancer.
"The launch of our professional MD line follows the highly successful performance of our consumer line that launched earlier this year in Japan," said Dr. Hans Keirstead, Aivita’s CEO. "The successive launch of consumer and professional lines, combined with a use of proceeds that is unprecedented in the beauty sector, make for a highly unique business plan that seems to be working extremely well."
Two days prior to the Air launch event, Aivita's consumer Root of Skin product line set record sales on home shopping channel QVC Japan's Today's Special Value.
Headquartered in Tokyo, Air Group is the Japanese agent of several global beauty brands and has a network of 300 high end beauty salons across Japan. Aivita’s Root of Skin MD products will be carried in Air Group affiliated salons with medical professionals.
Root of Skin MD is Aivita’s professional skincare line for skin rejuvenation, made possible through the same proprietary knowledge and expertise used to develop its cell therapies. The all-new actives complex SourceCode Technology contains the complete set of factors and supporting biological components present in young, healthy skin. Aivita uses 100% of proceeds from the sale of its professional Root of Skin MD skincare line and its consumer Root of Skin skincare line to support the treatment of women with ovarian cancer.
"The launch of our professional MD line follows the highly successful performance of our consumer line that launched earlier this year in Japan," said Dr. Hans Keirstead, Aivita’s CEO. "The successive launch of consumer and professional lines, combined with a use of proceeds that is unprecedented in the beauty sector, make for a highly unique business plan that seems to be working extremely well."
Two days prior to the Air launch event, Aivita's consumer Root of Skin product line set record sales on home shopping channel QVC Japan's Today's Special Value.
